Key result
Prophylactic inferior vena cava filter placement lacks well-defined target populations and randomized efficacy studies, despite promising preliminary data in high-risk patients.
Why the study?
Does prophylactic inferior vena cava filter placement prevent thrombosis in high-risk patients with contraindications to or inadequate response to standard thromboprophylaxis?
Does prophylactic inferior vena cava filter placement prevent thrombosis in high-risk patients with contraindications to or inadequate response to standard thromboprophylaxis?
While IVC filters are increasingly used for primary thromboprophylaxis in high-risk patients, randomized trials are needed to define efficacy and appropriate patient populations.
Answers are grounded in this paper and cite their sources.
Prophylactic IVC filter use warrants caution pending RCTs; leaves open optimal high-risk populations and efficacy confirmation.
Over the past several years there has been a rapid increase in the number of inferior vena cava (IVC) filters placed for primary thromboprophylaxis. Increased use has occurred in settings where other methods of thromboprophylaxis are viewed to be inadequate, technically challenging, or that place patients at an unacceptably high bleeding risk. These clinical services include trauma, bariatric surgery, neurosurgery, cancer, intensive care unit populations, and patients with a relative contraindication to anticoagulation. We review the studies to date addressing filter placement for these indications. Although preliminary data are promising, the patient populations most likely to benefit from prophylactic IVC filter placement have not been well defined, and randomized studies demonstrating efficacy have not been conducted. Moving forward, it will be critical to accomplish these two tasks if IVC filters are to continue to have a role in primary thromboprophylaxis.
No takes yet. Share an insight, caveat, or question.
Wehrenberg-Klee et al. (2012) conducted a review in Primary thromboprophylaxis. Inferior vena cava (IVC) filters was evaluated. Prophylactic inferior vena cava filter placement lacks well-defined target populations and randomized efficacy studies, despite promising preliminary data in high-risk patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: